Ottawa, Ontario - September 11, 2017
Joule, the Canadian Medical Association’s (CMA) newest company, is partnering with CognisantMD to bring the Ocean Platform for patient engagement and eReferrals to Canadian physicians.
Ocean is a secure, cloud-based platform that connects patients, health care providers and researchers through customizable patient forms, screening tools, surveys and referral forms. This patient-centric platform has the unique capacity to reduce language barriers between physicians and their patients, providing a much improved patient-doctor experience while also saving time and lives by automatically translating concise clinical notes into the electronic medical record.
The same platform can be used to share patient information between health care providers, allowing referrals to be sent electronically in real-time. Already more than 3,500 physicians across the country are using Ocean, which integrates seamlessly with leading electronic medical records systems in Canada.
In 2016, Dr. Doug Kavanagh, was among the inaugural physician-led Joule Innovation grant recipients, receiving $50,000 to support the development of the Ocean Platform and expansion of the Ocean Library, which now includes over 3,500 forms for clinical and administrative use.
“A year ago, we knew the Ocean Platform had the potential to change how patients, health care providers and researchers communicate and we’re proud to collaborate with CognisantMD to help provide access to this tool for CMA members.” explains Joule CEO Lindee David. “The days where patients complete paper forms on clipboards are coming to an end – we want to provide physicians with the latest technology to ensure the best use of their time and ensure that patients get the care they need.”
“We are honoured to have the Ocean Platform endorsed by Joule and supported by the Canadian Medical Association,” explains Dr. Doug Kavanagh, Medical Director and Co-Founder of CognisantMD. “Through this partnership, and our mutual commitment to bringing innovative technology to Canadian physicians, we hope to expand access to the platform across Canada, improving health care efficiency and patient care.”
Although Joule no longer has a formal endorsement program, we remain supportive of CognisantMD, recognizing it for the tremendous work it is doing to drive innovation in health care and improving access to care for all Canadians. We would like to emphasize that the discontinuation in our endorsement program in no way reflects a lack of confidence in our former co-brands’ products or services and is purely an internal programming matter specific to Joule and the CMA.